CTMX logo

CytomX Therapeutics, Inc. (CTMX)

Profile

Full Name

CytomX Therapeutics, Inc.

Ticker

NASDAQ: CTMX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 8, 2015

Indexes

Not included

Website

http://www.cytomx.com

Employees

119

Key Details

Price

$2.32(+3.11%)

Market cap

$365.50M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$138.10M(+36.45% YoY)

Annual EPS

$0.38(+3900.00% YoY)

PE ratio

4.73

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.32
    CTMX price is $2.32

    30-Day Relative Volume

    0.65
    CTMX 30-day relative volume is 0.65

    Price Performance

    Price Most recent change

    +3.11%
    CTMX price was up +3.11% on Jul 30, 2025

    Price YTD change

    +125.24%
    CTMX price is up +125.24% since January 1st

    Price 1-year change

    +68.12%
    CTMX price is up +68.12% year-on-year

    Price 3-year change

    +62.24%
    CTMX price is up +62.24% over the past 3 years

    Price Range

    Price All-time high

    $35.00
    CTMX price is currently -93.37% below its historical high of $35.00

    Price 3-year low

    $0.40
    CTMX price is currently +480.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $365.50M
    CTMX market capitalization is $365.50 million

    Market cap 3-year change

    +287.56%
    CTMX market capitalization is up +287.56% over the past 3 years

    Market cap All-time high

    $1.32B
    CTMX market capitalization is currently -72.34% below its historical high of $1.32 billion

    Market cap sector rank

    61.39%
    CTMX market capitalization is higher than 61.39% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +101.68%
    CTMX shares outstanding is up +101.68% year-on-year

    Shares Outstanding 3-Year Change

    +138.88%
    CTMX shares outstanding is up +138.88% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.20
    CTMX beta is 2.20

    200-day SMA

    $1.29
    CTMX price is currently +80.00% above its 200-day simple moving average

    50-day SMA

    $2.40
    CTMX price is currently -3.35% below its 50-day simple moving average

    RSI

    47.88
    CTMX 14-day relative strength index is 47.88

    Volume

    0.65
    CTMX 30-day relative volume is 0.65

    ATR

    $0.14
    CTMX average true range is $0.14

    10-day Historical Volatility

    37.26%
    CTMX 10-day historical volatility is 37.26%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $138.10M
    CTMX annual revenue is $138.10 million

    Revenue Analysts estimate

    $98.75M
    CTMX annual revenue is currently +39.85% higher than the consensus analysts' forecast

    Revenue 1-year change

    +36.45%
    CTMX annual revenue is up +36.45% year-on-year

    Revenue Sector rank

    59.5%
    CTMX annual revenue is higher than 59.5% of companies in Healthcare sector

    EPS

    EPS

    $0.38
    CTMX annual earnings per share is $0.38

    EPS Analysts estimate

    -$0.08
    CTMX annual earnings per share is currently -605.99% lower than the consensus analysts' forecast

    EPS 1-year change

    +3900%
    CTMX annual earnings per share is up +3900% year-on-year

    EPS Sector rank

    86.03%
    CTMX annual earnings per share is higher than 86.03% of companies in Healthcare sector

    Profit

    Gross profit

    -
    CTMX annual gross profit value is unknown

    Gross margin

    -
    CTMX annual gross profit margin value is unknown

    Operating profit

    $25.00M
    CTMX annual operating income is $25.00 million

    Operating margin

    18.10%
    CTMX annual operating profit margin is 18.10%

    Net income

    $31.87M
    CTMX annual net profit is $31.87 million

    Net margin

    23.08%
    CTMX annual net profit margin is 23.08%

    Expenses

    Total expenses

    $113.11M
    CTMX annual total expenses is $113.11 million

    Operating expenses

    $113.11M
    CTMX annual total operating expenses is $113.11 million

    Cost of goods sold

    -
    CTMX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $29.73M
    CTMX annual SGA is $29.73 million

    Depreciation and amortization

    $1.77M
    CTMX annual depreciation & amortization is $1.77 million

    Interest expense

    -
    CTMX annual interest expense value is unknown

    Income tax

    $224.00K
    CTMX annual income tax is $224.00 thousand

    EBIT & EBITDA

    EBIT

    $25.00M
    CTMX annual earnings before interest & taxes is $25.00 million

    EBITDA

    $26.76M
    CTMX annual EBITDA is $26.76 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $120.53M
    CTMX annual total assets is $120.53 million

    Non current assets

    $13.23M
    CTMX annual long term assets is $13.23 million

    Current assets

    $107.31M
    CTMX annual total current assets is $107.31 million

    Cash and cash equivalents

    $38.05M
    CTMX annual cash & cash equivalents is $38.05 million

    Accounts receivable

    $3.10M
    CTMX annual accounts receivable is $3.10 million

    Inventory

    -
    CTMX annual inventory value is unknown

    Liabilities

    Total liabilities

    $120.99M
    CTMX annual total liabilities is $120.99 million

    Long term liabilities

    $35.22M
    CTMX annual total long term liabilities is $35.22 million

    Current liabilities

    $85.77M
    CTMX annual total current liabilities is $85.77 million

    Accounts payable

    $1.09M
    CTMX annual accounts payable is $1.09 million

    Debt

    Total debt

    $9.38M
    CTMX annual total debt is $9.38 million

    Total debt 1-year change

    -32.84%
    CTMX annual total debt is down -32.84% year-on-year

    Long term debt

    $4.24M
    CTMX annual long term debt is $4.24 million

    Short term debt

    $5.14M
    CTMX annual short term debt is $5.14 million

    Equity & Capital

    Shareholders equity

    -$456.00K
    CTMX annual stockholders equity is -$456.00 thousand

    Book value

    -$456.00K
    CTMX annual book value is -$456.00 thousand

    Retained earnings

    -$691.58M
    CTMX annual retained earnings is -$691.58 million

    Working capital

    $21.53M
    CTMX annual working capital is $21.53 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$86.23M
    CTMX annual cash flow from operations is -$86.23 million

    Cash from operations 1-year change

    -53.89%
    CTMX annual cash flow from operations is down -53.89% year-on-year

    Cash from investing

    $99.70M
    CTMX annual cash flow from investing activities is $99.70 million

    Cash from investing 1-year change

    +166.17%
    CTMX annual cash flow from investing activities is up +166.17% year-on-year

    Cash from financing

    $7.52M
    CTMX annual cash flow from financing activities is $7.52 million

    Cash from financing 1-year change

    -75.12%
    CTMX annual cash flow from financing activities is down -75.12% year-on-year

    CAPEX

    CAPEX

    $310.00K
    CTMX annual capital expenditures is $310.00 thousand

    CAPEX 1-year change

    -63.1%
    CTMX annual capital expenditures is down -63.1% year-on-year

    Free Cash Flow

    Free cash flow

    -$86.54M
    CTMX annual free cash flow is -$86.54 million

    Free cash flow 1-year change

    -52.16%
    CTMX annual free cash flow is down -52.16% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CTMX annual gross profit margin value is unknown

    Operating margin

    18.10%
    CTMX annual operating profit margin is 18.10%

    Net margin

    23.08%
    CTMX annual net profit margin is 23.08%

    ROA & ROE

    ROA

    19.77%
    CTMX annual return on assets is 19.77%

    ROE

    -6988.82%
    CTMX annual return on equity is -6988.82%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    4.73
    CTMX price to earnings ratio is 4.73

    PE ratio Sector rank

    7.94%
    CTMX price to earnings ratio is higher than 7.94% of companies in Healthcare sector

    PB Ratio

    PB ratio

    14.59
    CTMX price to book ratio is 14.59

    PB ratio Sector rank

    92.96%
    CTMX price to book ratio is higher than 92.96% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.48
    CTMX price to sales ratio is 2.48

    PS ratio Sector rank

    44.93%
    CTMX price to sales ratio is higher than 44.93% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $326.05M
    CTMX enterprise value is $326.05 million

    Enterprise value Sector rank

    59.82%
    CTMX enterprise value is higher than 59.82% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    8.66
    CTMX EV/EBITDA is 8.66

    EV/EBITDA Sector rank

    81.48%
    CTMX EV/EBITDA is higher than 81.48% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.25
    CTMX annual current ratio is 1.25

    Quick ratio

    -
    CTMX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    CTMX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CTMX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CTMX piotroski f-score value is unknown

    Altman Z-Score

    -4.18
    CTMX altman z-score is -4.18

    Analyst ratings

    Recent major analysts updates

    May 20, 25 HC Wainwright & Co.
    Buy
    May 15, 25 Piper Sandler
    Overweight
    May 15, 25 HC Wainwright & Co.
    Buy
    Apr 14, 25 Piper Sandler
    Overweight
    Mar 7, 25 HC Wainwright & Co.
    Neutral
    Jan 7, 25 HC Wainwright & Co.
    Neutral
    Nov 11, 24 HC Wainwright & Co.
    Neutral
    Sep 13, 24 HC Wainwright & Co.
    Neutral
    Aug 22, 24 HC Wainwright & Co.
    Neutral
    Jun 27, 24 HC Wainwright & Co.
    Neutral

    Institutional Ownership

    Screeners with CTMX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for CytomX Therapeutics, Inc.?
    • Does CytomX Therapeutics, Inc. pay dividends?
    • What sector is CytomX Therapeutics, Inc. in?
    • What industry is CytomX Therapeutics, Inc. in?
    • What country is CytomX Therapeutics, Inc. based in?
    • When did CytomX Therapeutics, Inc. go public?
    • Is CytomX Therapeutics, Inc. in the S&P 500?
    • Is CytomX Therapeutics, Inc. in the NASDAQ 100?
    • Is CytomX Therapeutics, Inc. in the Dow Jones?
    • When was CytomX Therapeutics, Inc.'s last earnings report?
    • When does CytomX Therapeutics, Inc. report earnings?

    What is the ticker symbol for CytomX Therapeutics, Inc.?

    The ticker symbol for CytomX Therapeutics, Inc. is NASDAQ:CTMX

    Does CytomX Therapeutics, Inc. pay dividends?

    No, CytomX Therapeutics, Inc. does not pay dividends

    What sector is CytomX Therapeutics, Inc. in?

    CytomX Therapeutics, Inc. is in the Healthcare sector

    What industry is CytomX Therapeutics, Inc. in?

    CytomX Therapeutics, Inc. is in the Biotechnology industry

    What country is CytomX Therapeutics, Inc. based in?

    CytomX Therapeutics, Inc. is headquartered in United States

    When did CytomX Therapeutics, Inc. go public?

    CytomX Therapeutics, Inc.'s initial public offering (IPO) was on October 8, 2015

    Is CytomX Therapeutics, Inc. in the S&P 500?

    No, CytomX Therapeutics, Inc. is not included in the S&P 500 index

    Is CytomX Therapeutics, Inc. in the NASDAQ 100?

    No, CytomX Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is CytomX Therapeutics, Inc. in the Dow Jones?

    No, CytomX Therapeutics, Inc. is not included in the Dow Jones index

    When was CytomX Therapeutics, Inc.'s last earnings report?

    CytomX Therapeutics, Inc.'s most recent earnings report was on May 12, 2025

    When does CytomX Therapeutics, Inc. report earnings?

    The next expected earnings date for CytomX Therapeutics, Inc. is August 8, 2025
    On this page